Dingdang Health (Stock code: 09886) announced on May 12th that it has spent HK$12,300 to repurchase 13,000 shares.
Dingdang Health (09886) announced that the company repurchased 13,000 shares on May 12, 2026, at a cost of 12,300 Hong Kong dollars. The repurchase price per share was between 0.94-0.95 Hong Kong dollars.
DINGDANG HEALTH (09886) announced that on May 12, 2026, the company spent HK$12,300 to repurchase 13,000 shares at a repurchase price of HK$0.94-0.95 per share.
Related Articles
ZYLOXTB(02190) spent approximately HKD 1.1362 million to repurchase 51,000 shares on May 12th.
PW MEDTECH (01358) spent 992,000 Hong Kong dollars to repurchase 841,000 shares on May 12th.
CIG Shanghai (06166) will distribute a final dividend of $0.28 per share on June 25th.
ZYLOXTB(02190) spent approximately HKD 1.1362 million to repurchase 51,000 shares on May 12th.
PW MEDTECH (01358) spent 992,000 Hong Kong dollars to repurchase 841,000 shares on May 12th.
CIG Shanghai (06166) will distribute a final dividend of $0.28 per share on June 25th.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
